600511 Stock Overview
Distributes pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 5/6 |
My Notes
Capture your thoughts, links and company narrative
China National Medicines Corporation Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥34.71 |
| 52 Week High | CN¥38.00 |
| 52 Week Low | CN¥27.12 |
| Beta | 0.44 |
| 1 Month Change | 0.23% |
| 3 Month Change | 8.54% |
| 1 Year Change | 21.28% |
| 3 Year Change | 10.09% |
| 5 Year Change | 20.44% |
| Change since IPO | 981.87% |
Recent News & Updates
Returns On Capital Signal Tricky Times Ahead For China National Medicines (SHSE:600511)
Dec 01
We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease
Nov 12The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 25Recent updates
Returns On Capital Signal Tricky Times Ahead For China National Medicines (SHSE:600511)
Dec 01We Think China National Medicines (SHSE:600511) Can Manage Its Debt With Ease
Nov 12The China National Medicines Corporation Ltd. (SHSE:600511) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Oct 25China National Medicines Corporation Ltd.'s (SHSE:600511) Prospects Need A Boost To Lift Shares
Sep 26Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)
Sep 10Returns On Capital At China National Medicines (SHSE:600511) Paint A Concerning Picture
Jul 28China National Medicines Corporation Ltd.'s (SHSE:600511) Low P/E No Reason For Excitement
Jun 24China National Medicines (SHSE:600511) Has Announced That It Will Be Increasing Its Dividend To CN¥0.854
Jun 07Is China National Medicines (SHSE:600511) Using Too Much Debt?
Jun 05Calculating The Fair Value Of China National Medicines Corporation Ltd. (SHSE:600511)
May 21Capital Allocation Trends At China National Medicines (SHSE:600511) Aren't Ideal
Apr 10China National Medicines (SHSE:600511) Could Easily Take On More Debt
Feb 28Shareholder Returns
| 600511 | CN Healthcare | CN Market | |
|---|---|---|---|
| 7D | 0.2% | -2.4% | -0.5% |
| 1Y | 21.3% | -11.6% | 9.2% |
Return vs Industry: 600511 exceeded the CN Healthcare industry which returned -11.6% over the past year.
Return vs Market: 600511 exceeded the CN Market which returned 9.2% over the past year.
Price Volatility
| 600511 volatility | |
|---|---|
| 600511 Average Weekly Movement | 5.0% |
| Healthcare Industry Average Movement | 8.4% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 13.0% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 600511 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600511's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,138 | Guotao Tian | www.cncm.com.cn |
China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions.
China National Medicines Corporation Ltd. Fundamentals Summary
| 600511 fundamental statistics | |
|---|---|
| Market cap | CN¥26.19b |
| Earnings (TTM) | CN¥2.16b |
| Revenue (TTM) | CN¥51.19b |
12.1x
P/E Ratio0.5x
P/S RatioIs 600511 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600511 income statement (TTM) | |
|---|---|
| Revenue | CN¥51.19b |
| Cost of Revenue | CN¥47.36b |
| Gross Profit | CN¥3.83b |
| Other Expenses | CN¥1.67b |
| Earnings | CN¥2.16b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Mar 20, 2025
| Earnings per share (EPS) | 2.87 |
| Gross Margin | 7.49% |
| Net Profit Margin | 4.23% |
| Debt/Equity Ratio | 1.5% |
How did 600511 perform over the long term?
See historical performance and comparisonDividends
2.5%
Current Dividend Yield30%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/27 23:18 |
| End of Day Share Price | 2024/12/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
China National Medicines Corporation Ltd. is covered by 16 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Pei Cheng | China Galaxy Securities Co., Ltd. |
| Yanyin Zhu | China International Capital Corporation Limited |
| Ying Luo | China Merchants Securities Co. Ltd. |